Aristotle University Of Thessaloniki (AUTH)
Εκτίμηση των επίπεδων μορίων προσκόλλησης, ως πρώιμων δεικτών ενδοθηλιοπάθειας, σε μετεμμηνοπαυσιακές γυναίκες που λαμβάνουν τιμπολόνη
Abstract
dc:descriptionObjective. The first step in atherosclerosis is characterized by the adherence of leucocytes to cell adhesion molecules expressed by endothelial cells. The precise mechanism by which the steroid hormones may influence the process of atheromatosis remains unclear. The main goal of this study was the estimation of the effect of tibolone on the circulating levels of two adhesion molecules, ICAM-2 and P-selectine, in healthy postmenopausal women. A secondary goal was the investigation of the effect of tibolone on lipid profile and homocysteine levels. Patients and methods. Fifteen postmenopausal women (mean age±SE: 50.40±0.73 years) were treated with tibolone (2.5mg/day) for six months. The control group consisted of ten postmenopausal women who received no treatment (mean age±SE: 49.50±0.67 years). Serum concentrations of ICAM-2, P-selectine, HDL, LDL, triglycerides and homocysteine were evaluated in both groups in baseline, in 3 and 6 months time. Statistical analysis was done using t-test and General Linear Model. Results. ICAM-2. Tibolone group: 462.61±32.41 U/ml, 466.44 ±40.00 U/ml and 459.55±46.01 U/ml at 0, 3 and 6 months respectively. Control group: 429.08±39.70 U/ml, 470.25±48.99 U/ml and 368.88 ±56.35 U/ml at 0, 3 and 6 months respectively. No significant difference was revealed. P-selectine. Tibolone group: 134.32±9.48 ng/ml, 125.06±9.25 ng/ml and 111.17±8.63 ng/ml at 0, 3 and 6 months respectively. Control group: 107.69±11.62 ng/ml, 124.92±11.33 ng/ml and 108.04±10.54 ng/ml at 0, 3 and 6 months respectively. No significant difference was revealed. In addition, no significant differences were observed in cholesterol, HDL, LDL, triglycerides and homocysteine levels during the study period in both groups. Conclusion. Tibolone does not alterate the expression of ICAM-2 and P-selectine in postmenopausal women. Tibolone does not induce changes in endothelial function. Tibolone treatment does not appear to have any effect on lipid profile and on homocysteine levels. Treatment with tibolone seems to be safe concerning the cardiovascular system
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ζωγράφου, Χρήστος
- Zografou, Christos
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18717